Rossmore Private Capital’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.73M Sell
41,617
-86
-0.2% -$16K 0.9% 27
2025
Q1
$8.74M Sell
41,703
-683
-2% -$143K 1.08% 22
2024
Q4
$7.53M Sell
42,386
-543
-1% -$96.5K 0.93% 27
2024
Q3
$8.48M Buy
42,929
+999
+2% +$197K 1.05% 23
2024
Q2
$7.19M Sell
41,930
-574
-1% -$98.5K 0.94% 26
2024
Q1
$7.74M Sell
42,504
-383
-0.9% -$69.7K 1.01% 25
2023
Q4
$6.65M Hold
42,887
0.94% 28
2023
Q3
$6.39M Buy
42,887
+64
+0.1% +$9.54K 0.97% 27
2023
Q2
$5.77M Buy
42,823
+1,876
+5% +$253K 0.86% 30
2023
Q1
$6.53M Buy
40,947
+104
+0.3% +$16.6K 1.02% 28
2022
Q4
$6.6M Buy
40,843
+160
+0.4% +$25.9K 1.06% 26
2022
Q3
$5.46M Buy
40,683
+1,262
+3% +$169K 0.98% 29
2022
Q2
$6.04M Buy
39,421
+1,097
+3% +$168K 1.05% 24
2022
Q1
$6.21M Buy
38,324
+2,716
+8% +$440K 0.97% 23
2021
Q4
$4.82M Buy
35,608
+4
+0% +$542 0.75% 34
2021
Q3
$3.84M Buy
35,604
+84
+0.2% +$9.06K 0.66% 41
2021
Q2
$4M Buy
35,520
+849
+2% +$95.6K 0.68% 39
2021
Q1
$3.75M Sell
34,671
-1,218
-3% -$132K 0.7% 39
2020
Q4
$3.85M Buy
35,889
+2,197
+7% +$235K 0.78% 37
2020
Q3
$2.95M Buy
33,692
+400
+1% +$35K 0.69% 41
2020
Q2
$3.27M Buy
33,292
+2,931
+10% +$288K 0.9% 29
2020
Q1
$2.31M Buy
30,361
+4,187
+16% +$319K 0.8% 40
2019
Q4
$2.32M Buy
26,174
+5,525
+27% +$489K 0.71% 34
2019
Q3
$1.56M Hold
20,649
0.53% 44
2019
Q2
$1.5M Buy
20,649
+5,525
+37% +$402K 0.53% 38
2019
Q1
$1.22M Sell
15,124
-485
-3% -$39.1K 0.45% 44
2018
Q4
$1.44M Buy
15,609
+400
+3% +$36.9K 0.61% 32
2018
Q3
$1.44M Buy
15,209
+6,910
+83% +$653K 0.58% 35
2018
Q2
$769K Buy
8,299
+1,288
+18% +$119K 0.5% 44
2018
Q1
$664K Buy
7,011
+2,012
+40% +$191K 0.67% 37
2017
Q4
$483K Buy
+4,999
New +$483K 0.49% 46